bims-hypusi Biomed News
on Hypusine and eIF5A
Issue of 2025–04–13
one paper selected by
Sebastian J. Hofer, Max Delbrück Center



  1. Eur J Pharmacol. 2025 Apr 05. pii: S0014-2999(25)00350-4. [Epub ahead of print]997 177596
      The eukaryotic initiation factor 5A2 gene (EIF5A2) is a highly conserved and multifunctional gene that significantly influences various cellular processes, including translation elongation, RNA binding, ribosome binding, protein binding and post-translational modifications. Overexpression of EIF5A2 is frequently observed in multiple cancers, where it functions as an oncoprotein. Additionally, EIF5A2 is implicated in drug resistance through the regulation of various molecular pathways. In the review, we describe the structure and functions of EIF5A2 in normal cells and its role in tumorigenesis. We also elucidate the molecular mechanisms associated with EIF5A2 in the context of tumorigenesis and drug resistance. We propose that the biological roles of EIF5A2 in regulating diverse cellular processes and tumorigenesis are clinically significant and warrant further investigation.
    Keywords:  Drug resistance; EIF5A2; Hypusine; Signaling pathway; Tumorigenesis
    DOI:  https://doi.org/10.1016/j.ejphar.2025.177596